Literature DB >> 934750

Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.

J W Hansen, D L Loriaux.   

Abstract

We have examined the suppression of urinary pregnanetriol and 17-ketosteroids during treatment with cortisol, cortisone, prednisone, and dexamethasone in eight patients with congenital adrenal hyperplasia. A large individual variation in response to each agent was observed. In some individuals, cortisone is less effective than its generally accepted potency would indicate. At equivalent glucocorticoid dosage, dexamethasone was twice as effective as the other steroids in suppressing urinary 17-ketosteroids and pregnanetriol. The potency of dexamethasone in suppressing adrenal function was 80 times that of cortisol, about twice its generally accepted potency as a glucocorticoid or anti-inflammatory agent.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 934750

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Monitoring treatment in congenital adrenal hyperplasia.

Authors:  S Appan; P C Hindmarsh; C G Brook
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

Review 2.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review of current knowledge.

Authors:  G E Bacon; R P Kelch
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

3.  Glucocorticoid Regimens in the Treatment of Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis.

Authors:  Emma Whittle; Henrik Falhammar
Journal:  J Endocr Soc       Date:  2019-04-18

4.  Differential effects of hydrocortisone, prednisone, and dexamethasone on hormonal and pharmacokinetic profiles: a pilot study in children with congenital adrenal hyperplasia.

Authors:  Todd D Nebesio; Jamie L Renbarger; Zeina M Nabhan; Sydney E Ross; James E Slaven; Lang Li; Emily C Walvoord; Erica A Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2016-09-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.